Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine Specification

Origin of Medicine
India

Drug Type
General Medicines

Physical Form
Liquid

Dosage Guidelines
As per doc. suggestion

Storage Instructions
Dry & Cool place

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine Trade Information

Minimum Order Quantity
10 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine is a general medicine in liquid form, originating from India. This vaccine is designed to prevent meningococcal disease, which is caused by a bacteria that can lead to severe infections such as meningitis and sepsis. The vaccine is composed of a combination of polysaccharides and diphtheria toxoid, which helps to stimulate the bodys immune response against meningococcal bacteria. As per the doctors suggestion, the vaccine dosage should be administered. It is essential to store this vaccine in a dry and cool place to maintain its efficacy.

FAQs of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine:

Q: What is Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine?

A: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine is a liquid medicine used to prevent meningococcal disease, which is caused by a bacteria that can lead to severe infections such as meningitis and sepsis.